XERS
Xeris Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.17B
P/E Ratio
97.00
EPS
$0.07
Beta
0.90
52W High
$10.08
52W Low
$4.36
50-Day MA
$6.20
200-Day MA
$7.06
Dividend Yield
—
Profit Margin
3.81%
Forward P/E
84.75
PEG Ratio
—
About Xeris Pharmaceuticals Inc
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in Chicago, Illinois.
Fundamentals
| Revenue (TTM) | $314.85M |
| Gross Profit (TTM) | $270.44M |
| EBITDA | $48.08M |
| Operating Margin | 9.52% |
| Return on Equity | -617.00% |
| Return on Assets | 6.34% |
| Revenue/Share (TTM) | $1.91 |
| Book Value | $0.08 |
| Price-to-Book | 90.23 |
| Price-to-Sales (TTM) | 3.72 |
| EV/Revenue | 4.195 |
| EV/EBITDA | 24.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 38.30% |
| Shares Outstanding | $172.64M |
| Float | $163.74M |
| % Insiders | 3.38% |
| % Institutions | 62.30% |
Historical Volatility
HV 10-Day
40.52%
HV 20-Day
42.85%
HV 30-Day
43.70%
HV 60-Day
44.02%
HV Rank
20.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($11.29 target)
1
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026